DDDRA Pharmacology Main image
Announcements

The winners of EB 2008 Young Investigator Award:

1st Place
Jennifer M. Bomberger
- Dartmouth Medical School,
Pseudomonas aeruginosa toxin reduces MHC class I antigen presentation.

2nd Place
Yuri Karl Peterson
- Duke University Medical Center,
Northwestern University. Advantage of 2D-QSAR in the discovery of novel protein geranyltransferase inhibitor (GGTI) scaffolds.

3rd Place
Pey-Lih H. Littler
- ACADIA Pharmaceuticals,
University of South Florida College of Medicine. In vivo receptor occupancy of N-desmethylclozapine (ACP-104) and clozapine.



2006 Annual Report for DDDRA download

The Division for Drug Discovery, Drug Development and Regulatory Affairs (DDDRA) assists pharmacologists in industry, government and academia with interests in all phases of the drug development process. The goal of the Division is to promote interaction between discovery scientists, physicians and regulators as we attempt to integrate the broad expanse of skills required to translate the identification of a novel molecular target into a clinically useful therapeutic entity.

The DDDRA will serve to help its members teach, present and discuss the critical role of pharmacology in all phases of the drug discovery, development and registration process. The process encompasses, but is not limited to; target discovery and validation, medicinal chemistry, combinatorial chemistry, molecular modeling and drug design, structure-pharmacological function relationships, functional genomics and proteomics, high throughput screening, identification and development of natural products, nutraceuticals, pharmacokinetics and pharmacodynamics, clinical testing and drug regulation/registration, clinical contracting and pharmacoepidemiology and pharmacoeconomics. DDDRA sponsors symposia and/or colloquia on timely, related topics at annual meetings. Furthermore, the Division provides special venues at theses meetings for graduate students and post-doctoral fellows with related research activities and interests to present and discuss their work in a relaxed, social setting with other students, fellows and DDDRA members.




Please email comments, suggestions or questions to: Dora Walden,
Copyright 2007 Division for Drug Discovery, Drug Development and Regulatory Affairs.
All rights reserved.